top of page
Genetic Testing

Genetic Testing

The Role of Genetic Testing in Autism Evaluation

How CMA Supports Developmental and Autism Assessments

Genetic testing adds critical biological context to autism and developmental evaluations. While autism is diagnosed clinically, Chromosomal Microarray (CMA) helps identify underlying genetic factors that may influence development, behavior, learning and neurological function.

This information strengthens diagnostic pathways for Autism Centers, ABA programs, developmental pediatricians, neurologists and behavioral health providers.

Genetic Testing Scientist

Why Genetic Testing Matters

Genetic testing supports autism evaluations by:

  • Identifying chromosomal variations associated with developmental differences

  • Reducing uncertainty in complex clinical presentations

  • Supporting long-term planning and referral decisions

CMA detects copy number variations (CNVs), including microdeletions and microduplications, that are commonly linked to autism and developmental delay.

Clinical Value of CMA Results

CMA findings help care teams:

Improve diagnostic confidence

Align multidisciplinary providers

Support informed care planning

Communicate findings more clearly with families

This shared genetic insight strengthens continuity across pediatric, neurologic and behavioral health services.

Earlier Insight Supports Earlier Action

When genetic information is available earlier in the evaluation process, providers can:

  • Adjust intervention strategies sooner

  • Coordinate follow-up testing efficiently

  • Guide families with greater clarity

  • Faster insight supports better outcomes over time.

Why CMA Is the First-Line Genetic Test

CMA is widely recommended as the initial genetic test because it:

  1. Has strong diagnostic yield in autism and developmental delay

  2. Detects clinically meaningful CNVs

  3. Produces actionable results

  4. Delivers faster turnaround than sequencing

Why Centers Are Moving CMA In-House

Autism Lab Scientist

External laboratories often introduce delays that slow evaluations and care decisions. In-house CMA workflows allow centers to achieve:

  1. Predictable turnaround times

  2. Greater control over diagnostics

  3. Improved communication with families

  4. Fewer evaluation bottlenecks

CMA does not replace clinical evaluation, it enhances it.

Improve Your Autism Evaluation Process With Better CMA Access

If your center wants faster, clearer, more reliable CMA results, we can help you build an efficient in-house workflow.

info@AutismLabSetup.com

940-594-3775

Your center delivers answers.
We help you deliver them faster.

bottom of page